Carl Zeiss Meditec announces worldwide reduction of 1,000 jobs

Jena, May 12, 2026. The Jena-based medical technology company Carl Zeiss Meditec is planning extensive personnel cuts. As the company announced on Tuesday, 1,000 jobs are to be cut worldwide.

  • Company: Carl Zeiss Meditec AG (Headquarters in Jena)
  • Event: Planned job cuts
  • Scope: 1,000 jobs affected worldwide
  • Announcement: Tuesday, May 12, 2026

Tense economic situation reaches Jena flagship company

The general mood in the German and international economy continues to darken. In addition to a growing number of insolvency reports, even fundamentally healthy corporations are now resorting to drastic austerity measures. On Tuesday, this development hit the high-tech location of Jena: Carl Zeiss Meditec AG has announced the reduction of 1,000 jobs worldwide.

The company, which is one of the world’s leading providers in ophthalmology and microsurgery, is taking this step in response to the increasingly difficult market environment. Precise details on how the job cuts will be distributed across the individual international locations and particularly at the headquarters in Jena were not yet broken down in detail in the initial report.

Background: The importance of Carl Zeiss Meditec for Jena

Carl Zeiss Meditec AG, listed on the TecDAX and MDax, is one of the most important industrial employers in Ostthüringen. The company originates from the historic Zeiss Group, which has shaped the city of Jena as a global center for optics and photonics since the late 19th century. At the Jena site, highly complex lasers for eye correction, among other things, are developed and produced. Economic cuts at the city’s large optics groups (such as Zeiss, Jenoptik, or Schott) traditionally also have an impact on the close-knit network of regional suppliers as well as on the general labor market in the region.


Source:

Carl Zeiss Meditec to cut jobs | MDR.DE

Transparency note: This article was created automatically, editorially reviewed, and expanded with AI support.


Read original article in German